WON GI IM: Open Payments
NPI 1508932989 · AMITYVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,220 in 74 payments from 8 companies in 2025. Trend: 2023 $3,482 · 2024 $3,037 · 2025 $2,220
Food & beverage: $2,220
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $625 |
| Lundbeck LLC | 22 | $465 |
| E.R. Squibb & Sons, L.L.C. | 4 | $278 |
| ABBVIE INC. | 10 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $165 |
| Vanda Pharmaceuticals Inc. | 3 | $148 |
| Neurocrine BioSciences, Inc. | 5 | $127 |
Products named: REXULTI, LYBALVI, COBENFY, VRAYLAR, CAPLYTA, FANAPT, INGREZZA, ARISTADA.
Industry payments across NY — which companies pay providers there.
